Local Drug Delivery

The Controlled Particle Dispersion technology's ability to saturate the nasal mucosa and deliver to the paranasal sinuses can dramatically improve treatment of conditions such as rhinitis, chronic rhinosinusitis, cold and influenza.

Intranasal corticosteroids (INSs) effectively reduce the nasal inflammation that is a root cause of allergic rhinitis. By acting early and throughout the allergy process, INSs block more allergy mediators, treating the symptoms caused by nasal inflammation such as nasal congestion, sneezing, and runny or itchy nose. This class of medicine is considered first-line therapy when nasal congestion is the primary symptom of the patient's rhinitis.

  Home | Nasal Drug Delivery | Technology | Clinical Studies | Devices | Investors | News & Events | About Kurve | Contact

Copyright 2017, Kurve Technology, Inc. All Rights Reserved | Site Map
Technology Marketing